Yuan Chen

Yuan Chen

Auto-generated profile, based on publicly available information

Yuan Chen

Nanchang University Second Affiliated Hospital Department of Nephrology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Medicine
Verified
Journal Article
Open access
PDF file
DLDan Lu
Dan Lu
Jun LiuJun Liu
Jun Liu
YCYuan Chen
Yuan Chen
FCFei Chen
Fei Chen
HYHui Yang
Hui Yang
Ganglioneuroblastoma is usually located in the adrenal gland, retroperitoneal ganglia, or posterior mediastinum, but rarely occurs in the parapharyngeal space. A 4-year-old girl presented with complaint of progressive inspiratory dyspnea and dysphagia, accompanying left-side Horner's syndrome. Computed tomography (CT) scan revealed a giant mass with irregular low density in left oropharyngeal and posterior pharyngeal wall. The left carotid artery sheath was pushed to the right. After enhancement, the central part of the mass was strengthened, and the surrounding bones structures appeard normal. Magnetic resonance imaging (MRI) showed a solid mass in the left parapharyngeal space displacing the left carotid sheath posteriorly and laterally. A ganglioneuroblastoma was diagnosed. The girl was treated by surgery. The postoperative course was uneventful. There was no recurrence was observed during the 1-year follow-up. The primary cervical ganglioneuroblastoma is rare, we recommended the ganglioneuroblastoma should be considered in the differential diagnosis of a child presenting with a parapharyngeal space mass.

31 May 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
JLJialong Liang
Jialong Liang
YCYuan Chen
Yuan Chen
JZJintao Zhou
Jintao Zhou
MZMingfeng Zheng
Mingfeng Zheng
FLFeng Liu
Feng Liu
YJYong Ji&Ast
Yong Ji&Ast
Pulmonary arteriovenous fistula (PAVF) is a rare pulmonary vascular lesion, more than 80% of which is caused by congenital abnormal development of pulmonary capillaries. The incidence of PAVF ranges from 2/100,000 to 3/100,000, with no difference in the male and female ratio. Congenital PAVF is often associated with hereditary hemorrhagic telangiectasia (HHT). In this article, we report a patient with only congenital PAVF that was successfully treated by bilateral lung transplantation (BLT) with intraoperative venovenous extracorporeal membrane oxygenation (ECMO) support because both lungs have been affected by PAVF and secondary pulmonary hypertension. To the best of our knowledge, this is the first report of BLT for PAVF in China and the second report that explains the clinical course of a patient to receive BLT for congenital PAVF without HHT. Some investigators have proposed lung transplantation as a definitive treatment, but the results are controversial. On the basis of the current condition of this patient, we believe lung transplantation is a viable option for certain patients, but the long-term effect remains to be studied.

10 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
CYChen Yuan
Chen Yuan
JLJia Liu
Jia Liu
JGJiafu Guan
Jiafu Guan
BZBinghai Zhou
Binghai Zhou
HWHuajun Wu
Huajun Wu
ZHZhigang Hu
Zhigang Hu
To construct a practical prediction model for the risk of new-onset diabetes mellitus (DM) in patients with first-attack acute pancreatitis (AP) based on risk factors derived from demographic and clinical data. A total of 780 patients diagnosed with AP were retrospectively enrolled in the Second Affiliated Hospital of Nanchang University from June 2016 to June 2017. A series of exclusion criteria were applied and 396 patients were finally included. With a ratio of 2:1, patients were randomly divided into two groups named training (n = 264) and validation set (n = 132). Demographic and clinical data that may be risk factors of new-onset DM after first-attack AP were collected. Univariate and multivariate analyses were used to determine potential risk factors in the training set, and a predictive nomogram was constructed. Nomogram performance was determined in the training and validation sets concerning discrimination and calibration capabilities. Finally, clinical applicability of the nomogram was assessed in the validation set by decision curve analysis. The morbidity rate of new-onset DM after first-attack AP was 8.6% (34/396) in the included patient cohort. Hyperlipemia (OR = 6.87, 95%CI = 2.33 ~ 20.26, p = 0.000), GGT ≥ 40U/L (OR = 0.07, 95%CI = 0.03 ~ 0.27, p = 0.008), serum glucose ≥ 6.1mmol/L (OR = 7.73, 95%CI = 1.89 ~ 31.64, p = 0.004), CT grade ≥ 2 or 4 points (OR = 3.16 or 4.95, 95%CI = 1.05 ~ 9.45 or 1.12 ~ 21.89, p = 0.039 or 0.035) and APACHE II grade ≥ 8 points (OR = 3.82, 95%CI = 1.19 ~ 12.27, p = 0.024) were independent risk or protective factors and were assembled for nomogram construction. Internal and external validations showed good discrimination (Area under the receiver operating characteristic curve = 0.884 and 0.770) and calibration capabilities. The decision curve analysis showed good clinical applicability. We have developed a practical nomogram to predict the risk of new-onset DM after first-attack AP based on risk factors derived from demographic and clinical data, which would contribute to the identification and management of these high-risk patients.